Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OSR HealthOSRH -5.47%8 Gross Margin % is 33.06% as of Mar. 2026, which is 52% above its 10-year median of 21.69. GuruFocus rates OSRH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 733 Biotechnology companies, OSR Health ranks worse than 81.99% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. OSR Health's Gross Profit for the
three
months ended in Mar. 2026 was $0.16 Mil. OSR Health's Revenue for the
three
months ended in Mar. 2026 was $0.48 Mil. Therefore, OSR Health's Gross Margin % for the quarter that ended in Mar. 2026 was 33.06%.
The historical rank and industry rank for OSR Health's Gross Margin % or its related term are showing as below:
OSRH'
s Gross Margin % Range Over the Past 10 Years
Min: 20.41 Med: 21.69 Max: 22.97
Current: 22.25
During the past 4 years, the highestGross Margin % of OSR Health was 22.97%. The lowest was 20.41%. And the median was 21.69%.
OSRH's Gross Margin % is ranked worse than 81.99% of 733
companies
in the Biotechnology industry
Industry Median: 60.91
vs OSRH: 22.25
OSR Health had a gross margin of 33.06% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for OSR Health was 0.00% per year.
OSR Health (NAS:OSRH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
OSR Health had a gross margin of 33.06% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
OSR Health Gross Margin % Related Terms
OSR Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for OSR Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSRH vs TOVX, PBM, PHIO: Gross Margin % Comparison
For the Biotechnology subindustry, OSR Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OSR Health Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OSR Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where OSR Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
OSR Health (OSRH) has a Gross Margin % of 33.06% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on OSR Health and its competitors. This is 52% above median its historical median of 21.69. Over the past decade, OSR Health's Gross Margin % has ranged from 20.41 to 22.97. According to the industry distribution chart, OSR Health ranks #601 out of 733 companies in the Biotechnology industry, placing it in the top 82%.
Is OSR Health's Gross Margin % too high?
OSR Health's current Gross Margin % of 33.06% is 52% above median its 10-year median of 21.69. Over the past 10 years, this metric has ranged from a low of 20.41 to a high of 22.97. The Biotechnology industry median Gross Margin % is 60.91. OSR Health's value of 33.06% is 45.7% below this industry median. Based on the distribution chart, OSR Health ranks #601 out of 733 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OSR Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OSR Health's Gross Margin % compare to TOVX and PBM?
According to the Biotechnology industry distribution chart, OSR Health ranks #601 out of 733 companies for Gross Margin %. This places OSR Health in the lower half of its industry. The industry median Gross Margin % is 60.91. OSR Health's value of 33.06% is 45.7% below this benchmark. Historically, OSR Health's own Gross Margin % has ranged from 20.41 to 22.97 over the past decade. While the company's 10-year median is 21.69 vs. the industry median of 60.91, OSR Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OSR Health's current Gross Margin % of 33.06% is 45.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on OSR Health and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OSR Health's current Gross Margin % is 33.06%, which is 52% above median its own 10-year median of 21.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OSR Health stock overvalued right now?
OSR Health (OSRH) has a current Gross Margin % of 33.06%. The current Gross Margin % is 33.06%, which is 52% above median its 10-year median of 21.69 and 45.7% below the Biotechnology industry median of 60.91. OSR Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For OSR Health (OSRH), the current Gross Margin % is 33.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OSR Health Inc is a healthcare group that operates through a portfolio of subsidiary companies. It focuses on developing and supporting healthcare businesses and initiatives across the healthcare sector.
8GF Score
Get the complete analysis for OSRH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSRH has been successfully added to your 
